Early Efficacy and Exploratory Biomarker Data of Bel-sar in Patients with Intermediate-risk and High-risk Non-muscle-invasive Bladder Cancer.

Saved in:
Bibliographic Details
Title: Early Efficacy and Exploratory Biomarker Data of Bel-sar in Patients with Intermediate-risk and High-risk Non-muscle-invasive Bladder Cancer.
Authors: Linehan J; John Wayne Cancer Institute, Santa Monica, USA., Agarwal PK; University of Chicago, Chicago, USA., Penny X; Aura Biosciences, Boston, USA., Kates M; Johns Hopkins School of Medicine, Baltimore, USA., Jacob J; SUNY Upstate Medical University, Syracuse, USA., Lerner SP; Baylor College of Medicine, Houston, USA., Kines RC; Aura Biosciences, Boston, USA.; Laboratory of Cellular Oncology, NCI, NIH, Bethesda, USA., Schiller JT; Aura Biosciences, Boston, USA.; Laboratory of Cellular Oncology, NCI, NIH, Bethesda, USA., de Los Pinos E; Aura Biosciences, Boston, USA., Shore ND; START Carolinas/Carolina Urologic Research Center, Myrtle Beach, USA., Hopkins J; Aura Biosciences, Boston, USA., McQuaid J; Aura Biosciences, Boston, USA., Brookman-May SD; Aura Biosciences, Boston, USA.; University of Munich, LMU, Munich, Germany.
Source: European urology open science [Eur Urol Open Sci] 2026 Jun 13; Vol. 89, pp. 77-88. Date of Electronic Publication: 2026 Jun 13 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101771568 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-1683 (Electronic) Linking ISSN: 26661683 NLM ISO Abbreviation: Eur Urol Open Sci Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-1683
DOI:10.1016/j.euros.2026.05.017